The diversity of mast cell-derived mediators: implications for acute, subacute, and chronic cutaneous inflammatory disorders.
The mast cell in tissues represents an effector cell capable of elaboration of all the essential mediators of inflammation. The effects of uncontrolled activation may be divided into pharmacologic and inflammatory phases with attendant implications for the initiation of both acute and subacute pathologic processes. The elaboration of chemical mediators by the mast cell makes it possible to recruit blood cells and proteins essential to host defense by a controlled physiologic process that can proceed without significant local tissue damage. When uncontrolled, the same potentiality can be injurious, with the nature of the clinical problem depending upon the location of the cells, the intensity of activation, and the ratio of newly generated and preformed mediators released. The evidence that the mast cell can participate in each form of immunologic reaction--immediate, immune complex, and delayed- as a primary or secondary effector cell and the diversity of its products foretell an evolving recognition of its role in host defense and tissue injury. It is pertinent to develop further methods and criteria to define the nature and extent of mast cell participation in disease processes.
D000707:Anaphylaxis / Q000276:immunology; D000818:Animals; D006632:Histamine / Q000502:physiology; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000276:immunology*; D008407:Mast Cells / Q000276:immunology* / Q000473:pathology / Q000648:ultrastructure; D011453:Prostaglandins / Q000276:immunology; D013189:SRS-A / Q000276:immunology; D014582:Urticaria Pigmentosa / Q000276:immunology
D011453:Prostaglandins; D013189:SRS-A; D006632:Histamine